Facial plastic surgery
Conditions
Interventions
treatment group :alfentanil 6µg/kg and remimazolam 0.12 mg/kg
control group:alfentanil 6 µg/kg and propofol 1 mg/kg
Sponsors
Hangzhou Plastic Surgery Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Those who plan to undergo outpatient facial plastic surgery; 2. Age 18-75, regardless of gender; 3. Body mass index (BMI): 18.5-30 kg/m^2; 4. American Society of Anesthesiologists Grading (ASA): I~II; 5. The subjects voluntarily signed the informed consent for this study.
Exclusion criteria
Exclusion criteria: 1. Currently suffering from acute or chronic diseases and taking relevant drugs; 2. Two weeks before the operation had been drinking, smoking, long-term alcoholism; 3. Patients who used sedatives and antiemetic drugs 24 hours before surgery; 4. Suspected abuse of narcotic analgesics or sedatives; 5. Previous history of abnormal operation and anesthesia recovery; 6. Allergic to opioids, benzodiazepines, propofol and excipients; 7. Pregnant women or parturients with pregnancy planning; 8. Participated in other drug trials within three months; 9. Subjects deemed unsuitable for this study by researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subject Satisfaction Score (ISAS Score); | — |
Countries
China
Contacts
Public ContactYunpig Huang
Outcome results
None listed